Reduced testosterone levels in males with lone atrial fibrillation

Jiangtao Lai1, Dongchen Zhou, Shudong Xia

  • 1Department of Cardiology, the First Affiliated Hospital, School of Medicine Zhejiang University, Hangzhou, China. shang.yp@163.com

Clinical Cardiology
|January 15, 2009
PubMed

Insights

Low testosterone levels may increase the risk of lone atrial fibrillation (AF) in men. This study found lower testosterone in men with AF compared to healthy controls.

Area of Science:

  • Endocrinology
  • Cardiology
  • Men's Health

Background:

  • Sex hormones are crucial in cardiovascular disease development.
  • Testosterone and estradiol are down-regulated in coronary artery disease and heart failure.
  • The role of sex hormones in atrial fibrillation (AF) remains understudied.

Purpose of the Study:

  • To investigate the association between sex hormone levels and susceptibility to lone AF in men.
  • To determine if testosterone or estradiol levels differ in men with lone AF compared to controls.

Main Methods:

  • Fifty-eight men with lone AF and 58 healthy male controls were enrolled.
  • Exclusion criteria included specific medications and cardiovascular conditions.
  • Serum total testosterone and estradiol levels were measured using radioimmunoassay.

Main Results:

  • Men with lone AF had significantly lower mean testosterone levels than controls (476 vs. 514 ng/dl, p=0.005).
  • No significant difference in estradiol levels was observed between AF patients and controls (31.9 vs. 32.4 pg/ml, p=0.789).

Conclusions:

  • Reduced testosterone levels are associated with an increased susceptibility to lone atrial fibrillation in men.
  • Estradiol levels do not appear to be significantly associated with lone AF in this cohort.
Abstract

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...